Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Purpose: The purpose was to identify how the ICECAP-A and ICECAP-O have been used with adults who have neurological health conditions.
Methods: Following the Joanna Briggs Institute framework, a scoping review was conducted, searching five databases (Scopus, CINAHL, MEDLINE, Embase, and PsycINFO). Studies were included if participants were adults (age 18+ years) with neurological health conditions, and ICECAP-A or ICECAP-O were used in the study. Exclusions included studies about mental health conditions, protocols, and abstracts. Two authors screened abstracts and full texts independently. Conflicts were resolved through consensus. Data were categorized and synthesized.
Results: Search results included 1163 articles and 571 studies were screened. The team reviewed 37 full-text articles, with 14 studies included. Eleven studies utilized ICECAP-O; three utilized ICECAP-A. Nine studies were from Europe, three from Canada, and two from Australia. The uses of ICECAP measures included psychometric studies (9), economic evaluation (3), program evaluation (1), and testing associations (1). Nine studies focused on dementia, with 7 of those including proxy evaluations, two studies involved individuals with spinal cord injury, and one study each focused on individuals with Parkinson's disease, epilepsy, and various neurological conditions. Both ICECAP-O and ICECAP-A were referred to in the studies as measures of well-being, capability, quality of life or some combination.
Conclusions: ICECAP-O has not been thoroughly examined in neurological health conditions outside of dementia. There is potential for further psychometric testing of both ICECAP-A and ICECAP-O in neurological conditions and research into the application of capability measures in clinical and research settings.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11136-025-04055-1 | DOI Listing |